MedicalSystem Biotechnology Co EBITDA TCAC 5A

Que fait MedicalSystem Biotechnology Co ? MedicalSystem Biotechnology Co Ltd is a biotechnology company based in Ningbo, China, operating within the healthcare sector. The company focuses on the research, development, and manufacturing of bio-tech pharmaceutical products. It employs 2,473 full-time staff and completed its initial public offering (IPO) on April 22, 2015. MedicalSystem Biotechnology offers in-vitro diagnostic products, including reagents and instruments, and provides third-party medical diagnosis services. The company also produces and distributes reagent raw materials. Its primary market is domestic, with operations concentrated within China. The company's headquarters are located in Ningbo, Zhejiang Province. MedicalSystem Biotechnology's website is https://www.nbmksw.com/. The company's business activities include the development and production of diagnostic products, alongside the provision of related medical services. It operates as a public company listed on the Shenzhen Stock Exchange under the ticker symbol 300439.SZ and is identified by the ISIN CNE100001Z25. The company's operations are centered on the domestic Chinese market, with no indication of significant international presence. MedicalSystem Biotechnology is engaged in the production of pharmaceuticals and diagnostic tools, serving healthcare providers and institutions within China. MedicalSystem Biotechnology Co est l'une des entreprises les plus populaires sur Eulerpool.